CRD-4730, Encapsulation of microcrystalline cellulose into HPMC capsules to match the CRD-4730 active capsules in appearance
CRD-4730-201
Phase 2 small_molecule active
Quick answer
CRD-4730, Encapsulation of microcrystalline cellulose into HPMC capsules to match the CRD-4730 active capsules in appearance for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active